Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
細胞標的化された薬学的に活性な物質または標識送達系
Document Type and Number:
Japanese Patent JP7045370
Kind Code:
B2
Abstract:
The present invention relates to an isolated cellular targeted delivery system comprising a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and an active ingredient as well as methods for producing such isolated cellular targeted delivery system and uses of such system for therapy, in particular for therapy of cancer.

Inventors:
Crawl, Magdalena
Beni, Irena
Byokko, paola
Lyzier, Tomas
Boffi, Alberto
Schultz, Alexandra
Pirhi, Sofia
Toneca, Katazina
Urewitz, Katazina
Tachiak, Baltowmyay
Kiraga, Uukas
Application Number:
JP2019519948A
Publication Date:
March 31, 2022
Filing Date:
December 21, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Celis Age
International Classes:
C12N5/0783; A61K31/404; A61K31/53; A61K31/661; A61K31/675; A61K31/7088; A61K35/15; A61K35/17; A61K38/02; A61K45/00; A61K47/64; A61K49/00; A61K49/04; A61P29/00; A61P35/00; A61P37/02; C12N5/0781; C12N5/0786; C12N5/0787
Domestic Patent References:
JP2015519890A
JP2009533061A
JP2018520673A
JP2018518525A
Other References:
Biomaterials,2012年,Vol. 33,pp. 4195-4203
Nanomedicine: Nanotechnology, Biology, and Medicine,2014年,Vol. 10,pp. 561-569
Attorney, Agent or Firm:
Takashi Shoji
Yuriko Shinobu
Takuya Osugi
Hirata Midori